NEW YORK ( TheStreet) -- Depomed (Nasdaq: DEPO) hit a new 52-week low Tuesday as it is currently trading at $4.35, below its previous 52-week low of $4.45 with 193,829 shares traded as of 10:04 a.m. ET. Average volume has been 912,800 shares over the past 30 days. Depomed has a market cap of $273.5 million and is part of the health care sector and drugs industry. Shares are down 28.9% year to date as of the close of trading on Monday. Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. The company has a P/E ratio of 2.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Practice your DEPO trading strategies and win cash in our stock game.